JP2017535618A5 - - Google Patents

Download PDF

Info

Publication number
JP2017535618A5
JP2017535618A5 JP2017547075A JP2017547075A JP2017535618A5 JP 2017535618 A5 JP2017535618 A5 JP 2017535618A5 JP 2017547075 A JP2017547075 A JP 2017547075A JP 2017547075 A JP2017547075 A JP 2017547075A JP 2017535618 A5 JP2017535618 A5 JP 2017535618A5
Authority
JP
Japan
Prior art keywords
ethyl
tetrahydro
benzo
ylamino
acetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017547075A
Other languages
English (en)
Japanese (ja)
Other versions
JP6582056B2 (ja
JP2017535618A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/078058 external-priority patent/WO2016087370A1/en
Publication of JP2017535618A publication Critical patent/JP2017535618A/ja
Publication of JP2017535618A5 publication Critical patent/JP2017535618A5/ja
Application granted granted Critical
Publication of JP6582056B2 publication Critical patent/JP6582056B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017547075A 2014-12-01 2015-11-30 Cxcr7受容体調節剤 Expired - Fee Related JP6582056B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP2014076126 2014-12-01
EPPCT/EP2014/076126 2014-12-01
PCT/EP2015/078058 WO2016087370A1 (en) 2014-12-01 2015-11-30 Cxcr7 receptor modulators

Publications (3)

Publication Number Publication Date
JP2017535618A JP2017535618A (ja) 2017-11-30
JP2017535618A5 true JP2017535618A5 (cg-RX-API-DMAC10.html) 2018-12-20
JP6582056B2 JP6582056B2 (ja) 2019-09-25

Family

ID=54705645

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017547075A Expired - Fee Related JP6582056B2 (ja) 2014-12-01 2015-11-30 Cxcr7受容体調節剤

Country Status (7)

Country Link
US (1) US10202368B2 (cg-RX-API-DMAC10.html)
EP (1) EP3227263B1 (cg-RX-API-DMAC10.html)
JP (1) JP6582056B2 (cg-RX-API-DMAC10.html)
CN (1) CN107001279B (cg-RX-API-DMAC10.html)
CA (1) CA2963447A1 (cg-RX-API-DMAC10.html)
ES (1) ES2732437T3 (cg-RX-API-DMAC10.html)
WO (1) WO2016087370A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015030095B1 (pt) 2013-05-30 2023-02-28 Idorsia Pharmaceuticals Ltd Moduladores do receptor de cxcr7
EP3490986B1 (en) * 2016-07-28 2021-11-24 Idorsia Pharmaceuticals Ltd Piperidine cxcr7 receptor modulators
CN109776451B (zh) * 2017-11-15 2020-12-11 中山光禾医疗科技有限公司 光交联水凝胶材料的制备、原料、产品及应用
KR102502046B1 (ko) * 2018-01-26 2023-02-20 이도르시아 파마슈티컬스 리미티드 Cxcr7 수용체 작동제 (3s,4s)-1-시클로프로필메틸-4-{[5-(2,4-디플루오로-페닐)-이속사졸-3-카르보닐]-아미노}-피페리딘-3-카르복실산 (1-피리미딘-2-일-시클로프로필)-아미드의 결정질 형태
CN113412261A (zh) * 2019-04-08 2021-09-17 四川科伦博泰生物医药股份有限公司 苯并咪唑化合物、其制备方法及其用途
EP4326257A4 (en) * 2021-04-19 2025-03-12 ChemoCentryx, Inc. AZETIDINYLACETAMIDES AS CXCR7 INHIBITORS
CN120202194A (zh) 2022-11-16 2025-06-24 巴斯夫欧洲公司 作为杀真菌剂的取代的四氢苯并二氮杂䓬
WO2024104818A1 (en) 2022-11-16 2024-05-23 Basf Se Substituted benzodiazepines as fungicides
EP4619392A1 (en) 2022-11-16 2025-09-24 Basf Se Substituted benzodiazepines as fungicides

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116824D0 (en) * 1991-08-05 1991-09-18 Smithkline Beecham Corp Chemical compounds
US5639748A (en) * 1991-08-05 1997-06-17 Smithkline Beecham Corporation 6,9-disubstituted benzazepines having α-adrenoceptor blocking activity
RU2214405C2 (ru) 1998-02-18 2003-10-20 НьюроСёрч А/С Новые соединения и их применение в качестве положительных модуляторов амра-рецепторов
US7256201B2 (en) 2000-12-07 2007-08-14 Astrazeneca Ab Selective estrogen receptor-β ligands
JP2002371042A (ja) * 2001-06-12 2002-12-26 Takeda Chem Ind Ltd ジアミン化合物、その製造法および用途
ATE427933T1 (de) * 2002-12-20 2009-04-15 Chemocentryx Inc Inhibitoren der bindungder chemokine i-tac bzw. sdf-1 an den ccxckr2-rezeptor
EP1575874B1 (en) 2002-12-23 2010-09-08 Council of Scientific and Industrial Research Process for preparing hydrotalcite and brucite type posite charged layers
US20050192272A1 (en) * 2003-12-22 2005-09-01 Garland Marshall Substituted benzodiazepines as inhibitors of the chemokine receptor CXCR4
ATE486875T1 (de) 2005-11-10 2010-11-15 Chemocentryx Inc Substituierte chinolone und verwendungsverfahren
WO2008039420A2 (en) 2006-09-27 2008-04-03 Merck & Co., Inc. Novel inhibitors of beta-lactamase
MX2009004426A (es) * 2006-10-23 2009-08-12 Cephalon Inc Derivados biciclicos fusionados de 2,4-diaminopirimidina como inhibidores alk y c-met.
US20100331298A1 (en) 2007-12-10 2010-12-30 Cytopathfinder, Inc. Carboxamide Compounds and Their Use
PE20091339A1 (es) * 2007-12-21 2009-09-26 Glaxo Group Ltd Derivados de oxadiazol con actividad sobre receptores s1p1
EP2942346B1 (en) * 2009-02-17 2020-05-06 Syntrix Biosystems, Inc. Pyridinecarboxamides as cxcr2 modulators
AR091516A1 (es) 2012-06-22 2015-02-11 Actelion Pharmaceuticals Ltd Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida
BR112015030095B1 (pt) 2013-05-30 2023-02-28 Idorsia Pharmaceuticals Ltd Moduladores do receptor de cxcr7

Similar Documents

Publication Publication Date Title
CA2919498C (en) Aerosol nintedanib compounds and uses thereof
US9498467B2 (en) Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
JP2015526410A5 (cg-RX-API-DMAC10.html)
JP2024153665A (ja) P2x3調節剤としての置換イミダゾピリジン化合物の結晶形態およびそれらの使用
JP2012526843A5 (cg-RX-API-DMAC10.html)
JP2022521746A5 (cg-RX-API-DMAC10.html)
JP2012502017A5 (cg-RX-API-DMAC10.html)
BR112013012854B1 (pt) Composições farmacêuticas compreendendo inibidores de bcl-2 seletivos
KR20080065704A (ko) 의학적 이상의 치료 방법들, 조성물들, 및 키트들
JP2009541443A5 (cg-RX-API-DMAC10.html)
CN105263496A (zh) 依鲁替尼联合疗法
HRP20160036T1 (hr) Određeni kemijski entiteti, priprave i metode koji sadrže imidazopirimidin
JP2014511893A5 (cg-RX-API-DMAC10.html)
JP2018529770A5 (cg-RX-API-DMAC10.html)
JP2005538099A5 (cg-RX-API-DMAC10.html)
JP6912460B2 (ja) PI3Kβ阻害剤としてのキノキサリンおよびピリドピラジン誘導体
CN110169962B (zh) 用于治疗癌症的氧烯洛尔组合物
JP2008534552A (ja) 血栓症治療用の新規な医薬組成物
JP2008540672A (ja) 病状に起因する性的機能不全の治療方法
TW202019409A (zh) Bcl-2抑制劑與利妥昔單抗和/或苯達莫司汀或bcl-2抑制劑與chop聯合用藥的協同抗腫瘤作用
EP4408529A1 (en) Imidazopyridazine il-17 inhibitor compounds
JP2016520120A5 (cg-RX-API-DMAC10.html)
CN118201615A (zh) 喹唑啉酮化合物用于治疗癌症的新用途
JP2007169278A (ja) Luts処置用の医薬組合せ
JP2025061387A (ja) 複素環式タンパク質キナーゼ阻害剤を含む製剤